Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion type Assertion NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_head.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion description "[Additionally, the protein levels of G1 acting cyclin-dependent kinases (CDKs), CDK2, 4 and 6, was unaltered in Tam-treated lung cancer cells with the exception of CDK2 expression in H322 cells which was attenuated by Tam in a cell line-specific manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_provenance.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion evidence source_evidence_literature NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_provenance.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion SIO_000772 10435640 NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_provenance.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion wasDerivedFrom befree-20150227 NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_provenance.
- NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_assertion wasGeneratedBy ECO_0000203 NP301005.RA_993_KcDzvLtcnW7LsoKX4aMu2lXe1awjmzOHR42pGs130_provenance.